RGC
NVO

Roberts, Glore & Co’s Novo Nordisk NVO Stock Holding History

Roberts, Glore & Co’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
25,727
-10,791
-30% -$464K 0.31% 76
2026
Q1 		$1.34M Buy
36,518
+10,370
+40% +$491K 0.37% 67
2025
Q4 		$1.33M Sell
26,148
-668
-2% -$34.2K 0.35% 66
2025
Q3 		$1.49M Buy
26,816
+6,217
+30% +$364K 0.41% 61
2025
Q2 		$1.42M Buy
20,599
+9,510
+86% +$647K 0.42% 61
2025
Q1 		$770K Buy
11,089
+7,946
+253% +$656K 0.23% 95
2024
Q4 		$270K Sell
3,143
-62
-2% -$6.71K 0.08% 176
2024
Q3 		$382K Sell
3,205
-225
-7% -$30K 0.11% 146
2024
Q2 		$490K Hold
3,430
– – 0.15% 122
2024
Q1 		$440K Sell
3,430
-100
-3% -$11.9K 0.13% 131
2023
Q4 		$365K Sell
3,530
-138
-4% -$13.6K 0.11% 137
2023
Q3 		$334K Sell
3,668
-122
-3% -$10.7K 0.11% 140
2023
Q2 		$307K Buy
3,790
+46
+1% +$3.76K 0.1% 154
2023
Q1 		$298K Sell
3,744
-60
-2% -$4.25K 0.1% 151
2022
Q4 		$257K Buy
+3,804
New +$223K 0.09% 158
2022
Q3 		– Sell
-4,004
Closed -$223K – 189
2022
Q2 		$223K Hold
4,004
– – 0.07% 173
2022
Q1 		$222K Sell
4,004
-1,600
-29% -$82.1K 0.06% 190
2021
Q4 		$314K Hold
5,604
– – 0.08% 157
2021
Q3 		$269K Hold
5,604
– – 0.08% 160
2021
Q2 		$235K Buy
+5,604
New +$217K 0.07% 175

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Roberts, Glore & Co's NVO Position: Q2 2026 in Review

Roberts, Glore & Co reduced its Novo Nordisk (NVO) stake by 30% in Q2 2026, selling an estimated $464K and leaving 25,727 shares worth $1.23M. The position accounts for 0.31% of the portfolio, ranked #76.

Roberts, Glore & Co first reported a position in NVO in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.49M in Q3 2025. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Roberts, Glore & Co held 25,727 shares of Novo Nordisk worth $1.23M as of Q2 2026.
  • Roberts, Glore & Co sold 10,791 Novo Nordisk shares in Q2 2026, an estimated $464K.
  • Novo Nordisk made up 0.31% of Roberts, Glore & Co's portfolio in Q2 2026, its #76 holding.
  • Roberts, Glore & Co first reported a position in Novo Nordisk in Q2 2021 and has held it in 20 quarters since.
  • Roberts, Glore & Co's Novo Nordisk position peaked at $1.49M in Q3 2025.
  • 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Roberts, Glore & Co's 13F filing for Q2 2026, filed 11 Aug 2026.